Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sage Therapeutic Com (SAGE)

Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,200,337
  • Shares Outstanding, K 60,107
  • Annual Sales, $ 86,460 K
  • Annual Income, $ -541,490 K
  • 60-Month Beta 0.87
  • Price/Sales 13.77
  • Price/Cash Flow N/A
  • Price/Book 1.49
Trade SAGE with:

Options Overview Details

View History
  • Implied Volatility 67.48% ( +1.56%)
  • Historical Volatility 54.55%
  • IV Percentile 77%
  • IV Rank 18.62%
  • IV High 192.33% on 08/03/23
  • IV Low 38.92% on 03/23/23
  • Put/Call Vol Ratio 0.01
  • Today's Volume 3,204
  • Volume Avg (30-Day) 753
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 8,119
  • Open Int (30-Day) 9,916

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.64
  • Number of Estimates 13
  • High Estimate -0.90
  • Low Estimate -2.75
  • Prior Year -2.46
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.96 +2.16%
on 03/18/24
23.22 -16.58%
on 02/27/24
-3.90 (-16.76%)
since 02/16/24
3-Month
18.96 +2.16%
on 03/18/24
28.26 -31.46%
on 01/12/24
-1.78 (-8.42%)
since 12/18/23
52-Week
16.51 +17.29%
on 08/07/23
59.99 -67.71%
on 06/12/23
-23.38 (-54.69%)
since 03/17/23

Most Recent Stories

More News
Why Sage Therapeutics Stock Sank Today

A secondary stock sale and underwhelming quarterly results sent investors to the off-ramp.

SAGE : 19.37 (-3.00%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

SAGE : 19.37 (-3.00%)
Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month?

The pharmaceutical company's growth prospects have taken a big hit.

BIIB : 219.40 (+0.04%)
SAGE : 19.37 (-3.00%)
SAGE INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Sage Therapeutics, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Sage...

SAGE : 19.37 (-3.00%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

SAGE : 19.37 (-3.00%)
Why Shares of Sage Therapeutics Slumped This Week

The company got bad news from the FDA and saw increased losses.

BIIB : 219.40 (+0.04%)
SAGE : 19.37 (-3.00%)
2 Beaten-Down Stocks That Still Aren't Worth Buying

These companies aren't bargains at all.

NVAX : 5.14 (-2.84%)
SAGE : 19.37 (-3.00%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...

SAGE : 19.37 (-3.00%)
Is Sage Therapeutics a Contrarian Buy?

A regulatory setback weighed heavily on the drugmaker's shares Monday.

SAGE : 19.37 (-3.00%)
BIIB : 219.40 (+0.04%)
Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall, Monday, 8/7/2023

Stocks that traded heavily or had substantial price changes on Monday: Sovos Brands, Elanco Animal Health rise; Tyson Foods, Gogo fall

ELAN : 15.78 (+0.38%)
TSN : 56.09 (-0.11%)
VRTV : 169.99 (+0.02%)
SAGE : 19.37 (-3.00%)
FRPT : 108.41 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product...

See More

Key Turning Points

3rd Resistance Point 21.12
2nd Resistance Point 20.60
1st Resistance Point 19.99
Last Price 19.37
1st Support Level 18.86
2nd Support Level 18.34
3rd Support Level 17.73

See More

52-Week High 59.99
Fibonacci 61.8% 43.38
Fibonacci 50% 38.25
Fibonacci 38.2% 33.12
Last Price 19.37
52-Week Low 16.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar